Widimsky, P., Weaver, W. D., Van de Werf, F., Neumann, F.-J., Ardissino, D., Stebbins, A., … Granger, C. B. (2007). Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 49, pp. 241A-241A). New Orleans, LA: ELSEVIER SCIENCE INC.

Widimsky, Petr, W Douglas Weaver, Frans Van de Werf, Franz-Josef Neumann, Diego Ardissino, Amanda Stebbins, Annoud van t’Hof, Torsten T. Nielsen, Paul W. Armstrong, and Christopher B. Granger. “Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49:241A-241A. ELSEVIER SCIENCE INC, 2007.

Widimsky P, Weaver WD, Van de Werf F, Neumann F-J, Ardissino D, Stebbins A, et al. Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2007. p. 241A-241A.

Widimsky, Petr, et al. “Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 49, no. 9, ELSEVIER SCIENCE INC, 2007, pp. 241A-241A.

Widimsky P, Weaver WD, Van de Werf F, Neumann F-J, Ardissino D, Stebbins A, van t’Hof A, Nielsen TT, Armstrong PW, Granger CB. Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2007. p. 241A-241A.